Topics
Glioblastoma | Treatment | Clinical trials | Posaconazole
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Posaconazole
Mansouri A, de Macedo Filho L, Tufano E, Laukhuff H, Zacharia B,
Neighbors J, Green M, Derosia N, Sun D, Bhanja D, Tuohy K, Connor
J, Aregawi DG, Glantz M, Zadeh G.
A
phase 0 clinical trial to evaluate the neuropharmacological
profile of posaconazole for glioblastoma.
Neurooncol
Adv. 2026 Jul 2;8(1):vdag174. doi:
10.1093/noajnl/vdag174. PMID:
42494994. Trial
registration ID: NCT04825275. ˍ